Friday, 20 November 2026 Updated 23 min ago
The News Engine
Latest
Health United Kingdom

New pill shrinks pancreatic tumours in most trial patients

The Guardian reported that a drug called daraxonrasib has shown promising results in a trial involving patients with advanced pancreatic cancer that had…

Image accompanying the story: New pill shrinks pancreatic tumours in most trial patients
Image: Photograph: Jeff Moore/PA · via The Guardian

The Guardian reported that a drug called daraxonrasib has shown promising results in a trial involving patients with advanced pancreatic cancer that had spread beyond the pancreas. In the study, tumours stopped growing in almost all of the 61 participants, and in one out of twelve patients the cancer became undetectable. The trial enrolled people who had recently been diagnosed with the disease at an advanced stage. Researchers said the pill was able to shrink and, in some cases, potentially eliminate the tumours. The findings have been described as the biggest breakthrough in pancreatic‑cancer treatment in decades.

The trial’s outcomes suggest that daraxonrasib could become a new therapeutic option for patients with limited treatment choices, offering hope for improved survival and quality of life.

Why it matters

The results point to a possible new treatment for a cancer that is often diagnosed late and has few effective therapies.

Key details

Location
United Kingdom · Europe
Reported by
The Guardian
First reported
Section
Health

Sources

This is an independent summary. Read the full, original reporting from the publisher:

Read the full story at The Guardian

Spotted an error? Request a correction · How this summary was produced

Related Stories